Woodline Partners’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Hold |
622,682
| – | – | 0.01% | 737 |
|
|
2025
Q1 | $1.34M | Hold |
622,682
| – | – | 0.01% | 728 |
|
|
2024
Q4 | $2.41M | Sell |
622,682
-621,869
| -50% | -$2.41M | 0.02% | 623 |
|
|
2024
Q3 | $8.15M | Buy |
1,244,551
+1,966
| +0.2% | +$12.9K | 0.07% | 329 |
|
|
2024
Q2 | $9.01M | Buy |
1,242,585
+92,252
| +8% | +$669K | 0.09% | 260 |
|
|
2024
Q1 | $8.73M | Buy |
1,150,333
+354,107
| +44% | +$2.69M | 0.08% | 287 |
|
|
2023
Q4 | $3.62M | Buy |
796,226
+86,545
| +12% | +$394K | 0.04% | 342 |
|
|
2023
Q3 | $2.8M | Sell |
709,681
-972,232
| -58% | -$3.84M | 0.03% | 369 |
|
|
2023
Q2 | $5.26M | Hold |
1,681,913
| – | – | 0.06% | 278 |
|
|
2023
Q1 | $7.62M | Sell |
1,681,913
-259,826
| -13% | -$1.18M | 0.1% | 236 |
|
|
2022
Q4 | $8.02M | Hold |
1,941,739
| – | – | 0.11% | 244 |
|
|
2022
Q3 | $6.21M | Buy |
+1,941,739
| New | +$6.21M | 0.09% | 259 |
|